RxDoctor Payments Data

Al Barqawi, MD

Urology · Aurora, CONPI 1457541252

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,226 of the $5,041 with a category attached, or 64.0%. 9 manufacturers reported payments, led by Profound Medical Corp. at 39.8% of the total. 2025 is the largest year on record at $2,287, 4.9 times the $470 reported in 2019.

$5,041in general payments, 2019–2025

Across 33 payments — averaging $152.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Profound Medical Corp.$2K
  • Siemens Medical Solutions USA, Inc.$1K
  • Procept Biorobotics Corporation$530
  • Covidien LP$335
  • Angiodynamics, Inc.$233
  • Boston Scientific$212
  • plus $284 from 3 others
$111,037in research payments, 2019–2025

Across 12 payments — averaging $9253.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$111K

What the payments were for

  • Consulting fees$3357%
  • Travel & lodging$1,48029%
  • Food & beverage$3,22664%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Profound Medical Corp.3$2,005
Siemens Medical Solutions USA, Inc.15$1,441
Procept Biorobotics Corporation3$530
Covidien LP1$335
Angiodynamics, Inc.2$233
Boston Scientific6$212
Agiliti Health, Inc.1$183
Agiliti Surgical, Inc.1$83
Telix Pharmaceuticals1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,041 in reported general payments places this provider in the 65th percentile of 225 urology providers in Colorado.

See all urology providers in Colorado

Medicare billing

Part B allowed, 2024
$170,696
Medicare patients
491
Services billed
1,593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron39$36,851
Finasteride673$9,791
GemtesaVibegron11$8,132
Tamsulosin Hcl582$8,055
Solifenacin Succinate73$1,922
Dutasteride40$1,065
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst57$654
Alfuzosin Hcl ErAlfuzosin Hcl20$562
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim262$522
Ciprofloxacin Hcl66$134
Levofloxacin11$22

Paid to pharmacies, not to this prescriber.

Other urology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →